Literature DB >> 30846539

Evidence for a multimodal effect of riluzole in patients with ALS?

Adriaan D de Jongh1, Ruben P A van Eijk1,2, Leonard H van den Berg3.   

Abstract

Entities:  

Keywords:  ALS; motor neuron disease; neuromuscular

Mesh：

Substances：

Year:  2019        PMID： 30846539     DOI： 10.1136/jnnp-2018-320211

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

Review 1.  Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.

Authors:  Zoltán Papp; Piergiuseppe Agostoni; Julian Alvarez; Dominique Bettex; Stefan Bouchez; Dulce Brito; Vladimir Černý; Josep Comin-Colet; Marisa G Crespo-Leiro; Juan F Delgado; István Édes; Alexander A Eremenko; Dimitrios Farmakis; Francesco Fedele; Cândida Fonseca; Sonja Fruhwald; Massimo Girardis; Fabio Guarracino; Veli-Pekka Harjola; Matthias Heringlake; Antoine Herpain; Leo M A Heunks; Tryggve Husebye; Višnja Ivancan; Kristjan Karason; Sundeep Kaul; Matti Kivikko; Janek Kubica; Josep Masip; Simon Matskeplishvili; Alexandre Mebazaa; Markku S Nieminen; Fabrizio Oliva; Julius G Papp; John Parissis; Alexander Parkhomenko; Pentti Põder; Gerhard Pölzl; Alexander Reinecke; Sven-Erik Ricksten; Hynek Riha; Alain Rudiger; Toni Sarapohja; Robert H G Schwinger; Wolfgang Toller; Luigi Tritapepe; Carsten Tschöpe; Gerhard Wikström; Dirk von Lewinski; Bojan Vrtovec; Piero Pollesello
Journal:  J Cardiovasc Pharmacol       Date:  2020-07       Impact factor: 3.105

Review 2.  Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.

Authors:  Zoltán Papp; Piergiuseppe Agostoni; Julian Alvarez; Dominique Bettex; Stefan Bouchez; Dulce Brito; Vladimir Černý; Josep Comin-Colet; Marisa G Crespo-Leiro; Juan F Delgado; Istvan Édes; Alexander A Eremenko; Dimitrios Farmakis; Francesco Fedele; Cândida Fonseca; Sonja Fruhwald; Massimo Girardis; Fabio Guarracino; Veli-Pekka Harjola; Matthias Heringlake; Antoine Herpain; Leo Ma Heunks; Tryggve Husebye; Višnja Ivancan; Kristjan Karason; Sundeep Kaul; Matti Kivikko; Janek Kubica; Josep Masip; Simon Matskeplishvili; Alexandre Mebazaa; Markku S Nieminen; Fabrizio Oliva; Julius-Gyula Papp; John Parissis; Alexander Parkhomenko; Pentti Põder; Gerhard Pölzl; Alexander Reinecke; Sven-Erik Ricksten; Hynek Riha; Alain Rudiger; Toni Sarapohja; Robert Hg Schwinger; Wolfgang Toller; Luigi Tritapepe; Carsten Tschöpe; Gerhard Wikström; Dirk von Lewinski; Bojan Vrtovec; Piero Pollesello
Journal:  Card Fail Rev       Date:  2020-07-08

3.  Characteristics of serum metabolites in sporadic amyotrophic lateral sclerosis patients based on gas chromatography-mass spectrometry.

Authors:  Rui Jia; Qiaoyi Chen; Qingqing Zhou; Ronghua Zhang; Jiaoting Jin; Fangfang Hu; Xiao Liu; Xing Qin; Li Kang; Songzhen Zhao; Yonghui Dang; Jingxia Dang
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

4.  Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis.

Authors:  Benjamin Rix Brooks; James D Berry; Malgorzata Ciepielewska; Ying Liu; Gustavo Suarez Zambrano; Jeffrey Zhang; Melissa Hagan
Journal:  EClinicalMedicine       Date:  2022-08-04

5.  Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19.

Authors:  Ammar Al-Chalabi; Adriano Chiò; Charlotte Merrill; Gerry Oster; Rebecca Bornheimer; Wendy Agnese; Stephen Apple
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-10-27       Impact factor: 10.154
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.